The global dosimetry market is set to experience significant growth, with its valuation projected to rise from USD 3,144.10 million in 2024 to USD 4,882.60 million by 2034. According to Future Market Insights (FMI), this expansion represents a robust compound annual growth rate (CAGR) of 4.5% over the forecast period, driven by rising incidences of cardiovascular (CVD) diseases, cancer, and neurology-related disorders.
Dosimeters play a crucial role in monitoring and managing radiation exposure across medical and industrial applications. The surge in demand is fueled by the increasing adoption of advanced radiation therapies and diagnostics for critical illnesses like cancer and cardiovascular conditions. As healthcare systems prioritize safety and precision, dosimetry solutions are becoming indispensable tools in mitigating risks associated with radiation exposure.
Market players are responding to the growing demand by enhancing their product offerings and focusing on service excellence. This includes innovations in digital dosimetry systems, wearable devices, and software platforms that provide accurate and real-time radiation monitoring. These advancements aim to cater to the diverse needs of industries such as healthcare, nuclear energy, and manufacturing.
The dosimetry market’s promising trajectory highlights the broader trend of integrating technology to improve safety standards and health outcomes. With continued investment in research and development, key stakeholders are well-positioned to capitalize on expanding opportunities, ensuring sustainable growth and delivering superior solutions to global markets.
Key Drivers of Growth
- Rising Disease Incidence: The growing number of patients with cardiovascular and neurological conditions is increasing the need for precise radiation monitoring and treatment.
- Technological Advancements: Innovations in dosimetry technology are enhancing the accuracy and efficiency of radiation delivery in healthcare settings.
- Regulatory Compliance: Stricter safety regulations in various industries, including healthcare and nuclear energy, are pushing for improved dosimetry solutions.
Latest Developments Giving Shape to the Landscape
- In March 2024, Radiation Detection Company, which is a dosimetry service company dedicated to making radiotherapy safety affordable, easy-to-use, and reliable, for healthcare, veterinary, dental, and industrial fields, entered a contract with Thermo Fisher Scientific. Under this agreement, the former will distribute and service the digital dosimetry solution of Thermo Fisher Scientific.
- In April 2023, NUS researchers invented an affordable and ingestible capsule that acts as an X-ray dosimeter for real-time radiotherapy monitoring. The capsule monitors the temperature, radiation dose, and pH in the gastrointestinal tract in real-time, and has the potential to benefit gastric cancer patients undertaking radiotherapy.
- In July 2021, the World Health Organization (WHO) and IAEA introduced a new type of dosimetry audit, which is available as a cost-free service to radiotherapy centers. This will help hospitals across the globe to tackle the growing cancer burden.
A Comprehensive Full Report
Top Companies in the Dosimetry Market
- Honeywell
- Fisher Scientific Inc.
- Landauer, Inc. (Fortive)
- Mirion Technologies Inc.
- Fuji Electric Corporation of America
- Polimaster Inc.
- JP Laboratories Inc.
- X-Z Lab Inc.
- Ludlum Measurements Inc
- Laurus Systems Inc.
- Far West Technology Inc.
- S.E. International Inc.
- Others
Dosimetry Market Segmentation
By Product Type:
- Personal Electronic Dosimeter
- Self-reading Dosimeters
- Processed Dosimeters
By Modality:
- Wearable
- Collar level
- Chest level
- Waist level
- Wrist level
- Finger level
- Non-wearable
By Energy:
- Active Dosimeters
- Passive Dosimeters
- Optically Stimulated Luminescence Dosimeter (OSLD)
- Thermoluminescence Dosimeters (TLD)
- Radiophotoluminescence (RPL)
By Different End Users of Dosimetry:
- Industrial
- Medical
- Oil and Gas
- Defense, Homeland Security
- Mining
- Environmental
- Others
By Region:
- North America
- Europe
- Asia Pacific
- Middle East and Africa
- Latin America
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-347-918-3531
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube